Clinical Trial Update: A Single Arm Trial With Resolute Onyx in ONE-Month DAPT for High-Bleeding Risk Patients Who Are Considered One-Month Clear (Onyx ONE Clear) [NA]

View source ↗

Summary

A single-arm clinical trial evaluating ONE-Month Dual Antiplatelet Therapy (DAPT) using Resolute Onyx for high-bleeding-risk patients deemed One-Month Clear; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• RESOLUTE ONYX

Snippet

Sponsor: Medtronic Vascular | Conditions: Coronary Artery Disease | NA | Status: COMPLETED | Results posted: 2021-05-06